Get the Stockscreener App
5.94
1.49%
-0.11
Terns Pharmaceuticals Inc stock is traded at $5.94, with a volume of 643.88K.
It is down -1.49% in the last 24 hours and up +55.61% over the past month.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.
See More
Previous Close:
$6.05
Open:
$6.09
24h Volume:
643.88K
Relative Volume:
0.74
Market Cap:
$519.22M
Revenue:
-
Net Income/Loss:
$-95.90M
P/E Ratio:
-4.50
EPS:
-1.32
Net Cash Flow:
$-79.09M
1W Performance:
+5.67%
1M Performance:
+55.61%
6M Performance:
+33.63%
1Y Performance:
-33.85%
1-Day Range:
$5.86
$6.11
1-Week Range:
$5.55
$6.2099
52-Week Range:
$1.865
$11.40
Terns Pharmaceuticals Inc Stock (TERN) Company Profile
Name
Terns Pharmaceuticals Inc
Sector
Industry
Phone
650-525-5535 EXT.101
Address
1065 EAST HILLSDALE BLVD., SUITE 100, FOSTER CITY
Compare TERN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TERN
Terns Pharmaceuticals Inc
|
5.945 | 528.39M | 0 | -95.90M | -79.09M | -1.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.85 | 120.60B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.22 | 60.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
327.80 | 42.87B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
595.31 | 36.23B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.37 | 31.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Terns Pharmaceuticals Inc Stock (TERN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-28-25 | Initiated | William Blair | Mkt Perform |
| Oct-31-24 | Initiated | Oppenheimer | Outperform |
| Jun-22-23 | Initiated | Mizuho | Buy |
| Jun-07-23 | Initiated | Jefferies | Buy |
| May-31-23 | Initiated | ROTH MKM | Buy |
| May-08-23 | Initiated | BMO Capital Markets | Outperform |
| Feb-14-23 | Initiated | JMP Securities | Mkt Outperform |
| Feb-07-23 | Initiated | UBS | Buy |
| Sep-12-22 | Initiated | H.C. Wainwright | Neutral |
| Sep-14-21 | Resumed | Goldman | Buy |
| Mar-02-21 | Initiated | Cowen | Outperform |
| Mar-02-21 | Initiated | Goldman | Buy |
| Mar-02-21 | Initiated | JP Morgan | Overweight |
View All
Terns Pharmaceuticals Inc Stock (TERN) Latest News
What institutional flow reveals about Terns Pharmaceuticals Inc.Market Timing Strategy with Technical Filters - Newser
What are the technical indicators suggesting about Terns Pharmaceuticals Inc.Powerful growth strategies - jammulinksnews.com
How strong is Terns Pharmaceuticals Inc. company’s balance sheetCapitalize on emerging investment opportunities - jammulinksnews.com
Should I hold or sell Terns Pharmaceuticals Inc. stock in 2025Navigate the market with precision insights - jammulinksnews.com
How volatile is Terns Pharmaceuticals Inc. stock compared to the marketAchieve rapid portfolio growth with expert guidance - jammulinksnews.com
What is the risk reward ratio of investing in Terns Pharmaceuticals Inc. stockBreakthrough profit margins - jammulinksnews.com
Published on: 2025-07-28 01:38:12 - jammulinksnews.com
What makes Terns Pharmaceuticals Inc. stock price move sharplyFree Stock Market Real-Time Monitoring - Newser
What analysts say about Terns Pharmaceuticals Inc. stockMassive profits - Autocar Professional
What drives Terns Pharmaceuticals Inc. stock priceAccelerated earnings growth - PrintWeekIndia
Should I buy Terns Pharmaceuticals Inc. stock before earningsFree Investment Timing Strategies - jammulinksnews.com
Why Terns Pharmaceuticals Inc. stock is on top investor watchlistsRapid profit acceleration - jammulinksnews.com
Is Terns Pharmaceuticals Inc. a good long term investmentExceptional profit potential - PrintWeekIndia
What institutions are buying Terns Pharmaceuticals Inc. stock nowExceptional portfolio growth - jammulinksnews.com
Terns Pharmaceuticals Inc. Stock Analysis and ForecastUnmatched market gains - jammulinksnews.com
Why Terns Pharmaceuticals Inc. stock attracts strong analyst attentionDaily Price Surge List - Newser
Terns Pharmaceuticals Inc Stock (TERN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.94%
1.30%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):